Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.50 USD
Change Today +0.29 / 13.12%
Volume 1.5M
SYN On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 8:04 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

synthetic biologics inc (SYN) Snapshot

Open
$2.18
Previous Close
$2.21
Day High
$2.56
Day Low
$2.18
52 Week High
07/15/15 - $4.32
52 Week Low
10/16/14 - $1.34
Market Cap
221.3M
Average Volume 10 Days
1.1M
EPS TTM
$-0.53
Shares Outstanding
88.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SYNTHETIC BIOLOGICS INC (SYN)

synthetic biologics inc (SYN) Related Bloomberg News

View More Bloomberg News

synthetic biologics inc (SYN) Related Businessweek News

No Related Businessweek News Found

synthetic biologics inc (SYN) Details

Synthetics Biologics, Inc., a clinical-stage biotechnology company, develops pathogen-specific therapies for serious infections and diseases with a focus on protecting the microbiome. It is developing an oral biologic to protect the gut microbiome (gastrointestinal (GI) microflora) from intravenous (IV) antibiotics for the prevention of C. difficile infection; an oral statin treatment to reduce the impact of methane producing organisms on irritable bowel syndrome with constipation (IBS-C); and a monoclonal antibody combination for the treatment of Pertussis. The company is also developing a Phase II oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS. It has collaboration agreements with Intrexon Corporation, The University of Texas at Austin, and Cedars-Sinai Medical Center; sublicense agreement with Meda AB; and license agreements with McLean Hospital and The Regents of University of California. The company was formerly known as Adeona Pharmaceuticals, Inc. and changed its name to Synthetics Biologics, Inc. in February 2012. Synthetics Biologics, Inc. was founded in 2001 and is headquartered in Rockville, Maryland.

20 Employees
Last Reported Date: 08/10/15
Founded in 2001

synthetic biologics inc (SYN) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $499.0K
Compensation as of Fiscal Year 2014.

synthetic biologics inc (SYN) Key Developments

Synthetic Biologics Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Synthetic Biologics Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported loss from operations of $9,730,000 compared to $4,651,000 a year ago. Net loss attributable to the company and subsidiaries was $13,623,000 or $0.19 per basic and diluted share compared to $4,556,000 or $0.08 per basic and diluted share a year ago. For the six months, the company reported loss from operations of $17,937,000 compared to $8,490,000 a year ago. Net loss attributable to the company and subsidiaries was $25,981,000 or $0.14 per basic and diluted share compared to $8,394,000 or $0.36 per basic and diluted share a year ago.

Synthetic Biologics Inc. to Report Q2, 2015 Results on Aug 10, 2015

Synthetic Biologics Inc. announced that they will report Q2, 2015 results at 8:01 PM, GMT Standard Time on Aug 10, 2015

Synthetic Biologics Inc., Q2 2015 Earnings Call, Aug 10, 2015

Synthetic Biologics Inc., Q2 2015 Earnings Call, Aug 10, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SYN:US $2.50 USD +0.29

SYN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SYN.
View Industry Companies
 

Industry Analysis

SYN

Industry Average

Valuation SYN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SYNTHETIC BIOLOGICS INC, please visit www.syntheticbiologics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.